Rimon Consulting & Management Services Ltd. (TLV:RMON)

Regulus Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,087	1,552	1,276	1,089	1,364	-
Market Cap Growth	26.37%	21.64%	17.18%	-20.18%	-	-
Enterprise Value	2,377	1,751	1,407	1,027	1,540	-
Last Close Price	57.60	43.00	34.66	28.85	35.81	-
PE Ratio	34.68	25.86	19.97	21.04	46.28	-
PS Ratio	2.19	1.70	1.70	2.36	4.67	-
PB Ratio	3.74	2.91	2.53	2.28	3.13	-
P/TBV Ratio	3.91	3.05	2.65	2.41	3.32	-
P/FCF Ratio	-	-	227.48	-	80.26	-
P/OCF Ratio	131.57	13.68	19.65	40.72	30.93	-
EV/Sales Ratio	2.50	1.92	1.88	2.23	5.28	-
EV/EBITDA Ratio	18.99	15.29	13.95	13.84	62.72	-
EV/EBIT Ratio	30.06	22.14	19.77	18.51	117.84	-
EV/FCF Ratio	-20.91	-	250.87	-	90.61	-
Debt / Equity Ratio	1.13	1.22	0.64	0.55	0.52	1.15
Debt / EBITDA Ratio	5.01	5.23	3.08	3.32	8.20	5.21
Debt / FCF Ratio	-	-	58.03	-	13.32	-
Asset Turnover	0.68	0.68	0.71	0.51	0.44	-
Quick Ratio	1.31	1.22	1.09	1.50	1.59	0.92
Current Ratio	1.31	1.31	1.20	1.54	1.63	0.97
Return on Equity (ROE)	11.40%	11.81%	13.28%	11.15%	9.25%	-
Return on Assets (ROA)	3.58%	3.69%	4.23%	3.80%	1.23%	-
Return on Capital (ROIC)	4.94%	4.92%	5.67%	4.95%	1.57%	-
Return on Capital Employed (ROCE)	8.60%	8.80%	10.40%	8.90%	2.50%	11.10%
Earnings Yield	2.88%	3.87%	5.01%	4.75%	2.16%	-
FCF Yield	-5.45%	-0.23%	0.44%	-2.82%	1.25%	-
Dividend Yield	-	-	2.63%	2.48%	-	-
Payout Ratio	54.24%	54.31%	39.92%	28.98%	61.06%	46.70%
Buyback Yield / Dilution	0.45%	0.68%	-0.01%	-12.56%	-12.42%	-0.41%
Total Shareholder Return	-	0.68%	2.62%	-10.08%	-12.42%	-0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.